ValuEngine Downgrades Edap Tms (NASDAQ:EDAP) to Hold

Edap Tms (NASDAQ:EDAP) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, ValuEngine reports.

EDAP has been the topic of a number of other research reports. TheStreet downgraded Edap Tms from a “b-” rating to a “d+” rating in a report on Monday, June 17th. Zacks Investment Research upgraded Edap Tms from a “sell” rating to a “hold” rating in a research report on Tuesday, July 16th. Finally, HC Wainwright set a $7.00 price target on Edap Tms and gave the stock a “buy” rating in a research report on Tuesday, June 11th.

EDAP stock traded down $0.12 during trading on Thursday, reaching $3.10. The stock had a trading volume of 65,500 shares, compared to its average volume of 190,929. Edap Tms has a 52 week low of $1.35 and a 52 week high of $5.42. The firm’s 50 day moving average is $2.75. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.97 and a current ratio of 2.40. The company has a market capitalization of $93.38 million, a price-to-earnings ratio of 155.00 and a beta of 1.94.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, May 15th. The medical equipment provider reported $0.01 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.01. Edap Tms had a negative return on equity of 1.13% and a negative net margin of 0.36%. The company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $13.25 million. Research analysts predict that Edap Tms will post 0.08 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Edap Tms stock. Hilton Capital Management LLC purchased a new position in Edap Tms SA (NASDAQ:EDAP) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,000 shares of the medical equipment provider’s stock, valued at approximately $75,000. Hilton Capital Management LLC owned approximately 0.09% of Edap Tms as of its most recent SEC filing. 10.32% of the stock is currently owned by hedge funds and other institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

See Also: Preferred Stock

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with's FREE daily email newsletter.